Found 981 clinical trials
Phase I Evaluation of Two Zika Viruses for Use in Controlled Human Infection Models (CHIM)
This research study will test one of 2 different Zika viruses (ZIKV) so we can find a ZIKV we can safely give to people in the future to test vaccines. If you join, you will have one or more screening visits. If you are healthy and your labs are normal, you …
- 3 views
- 09 Dec, 2021
- 1 location
Provider Recommendation and HPV Vaccination (HPVV)
guidelines recommending the HPV vaccine and interventions encouraging parents to vaccinate their children to prevent HPV-related cancers, the vaccination rate for teens remains low according to a 2018
- 31 views
- 30 May, 2022
- 1 location
Developing and Testing a COVID-19 Vaccination Acceptance Intervention (CoVAcS)
, largely owing to vaccine hesitancy and lack of access to vaccination. Thus, there is a critical need for evidence-based interventions to increase COVID-19 vaccine acceptance and access among Veterans
- 0 views
- 29 Apr, 2022
- 1 location
Multilevel Interventions to Enhance Provider Recommendations for HPV Vaccination
Each year the human papillomavirus (HPV) causes 30,000 cancers in the United States despite the availability of very effective and safe vaccines. Uptake of the HPV vaccine has been disappointingly low and lags behind other adolescent vaccines. This study seeks to test interventions targeting health care system, provider, and patient …
- 156 views
- 04 Oct, 2022
- 1 location
Edtech-HPV: A Community Approach Using Education and Technology to Increase HPV Vaccination (Edtech-HPV)
increasing the rate of HPV vaccination completion among children of Mexican Americans. The investigator's have extended the duration that participants are followed in assessing their child's uptake of
- 429 views
- 31 Jan, 2022
- 3 locations
Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults
Cellular and humoral immune responses before and after seasonal influenza vaccination will be assessed. Each year, up to 100 participants will be enrolled. To study age-specific differences in
- 4 views
- 14 Nov, 2021
- 1 location
Community Network-driven COVID-19 Testing and Vaccination of Vulnerable Populations in the Central US (C3)
This C3 project, Community network-driven COVID-19 testing of vulnerable populations in the Central US, will implement and evaluate a COVID-19 testing and vaccination approach that combines an
- 0 views
- 10 Apr, 2022
- 1 location
Evaluation of the Immunogenicity, Safety, and Tolerability of a Single Dose of ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2: a Phase 3 Trial in Two Parts-Randomized, Double-blind, Active Controlled and Open-label, Single-arm
compare vaccination with a single 100 µg dose of ABNCoV2 to a single 30 µg adult booster dose of Comirnaty (active control) in adult subjects who either previously completed primary vaccination (Cohort 1
- 0 views
- 14 Oct, 2022
- 3 locations
A PHASE 1/2 RANDOMIZED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST INFLUENZA IN HEALTHY INDIVIDUALS
. Participants will receive at Vaccination 1 either: 1 of 4 dose levels of mIRV (either A or B Strain), 1 of 4 dose levels of bIRV (containing both A and B strains), qIRV (at 1
- 30 views
- 28 Oct, 2022
- 83 locations
COVID-19 VACCINE SAFETY AND EFFECTIVENESS
standard 3-dose schedule with an interval of 12 weeks (first-second dose) and 24 weeks (second-thrid dose), in the vaccination campaign against SARS-CoV-2 to assess the safety, efficacy and duration of the
- 0 views
- 02 Dec, 2021
- 1 location